Elizabeth Whittington

The NCNN recommends testing for Lynch syndrome for at-risk individuals, regardless of whether they have colorectal cancer.

Updates from ASCO's Genitourinary Cancers Symposium.

Xalkori improves survival in patients with ALK-positive lymphoma.

Gazyva may become a standard treatment for older, sicker patient with CLL.

Patients with multiple myeloma fare better with continuous Revlimid (lenalidomide).

Recent studies show that two common colorectal cancer screening practices are both effective.

Updates from the annual meeting of the American Society of Hematology.